Search bioRxiv⌕ Search

Biology subjects

cui, X.

Publications and source records attributed to cui, X..

2 recordsLinked to original sources

Exploring protein conformational ensembles using evolutionary conditional diffusion

Protein conformational ensembles encode the dynamic landscapes underlying biological function, regulation, and allostery. Accurately reconstructing such ensembles while balancing conformational distributions accuracy and physical plausibility remains a fundamental challenge in structural biology, particularly when dynamic data is scarce. Here, we propose DiffEnsemble, a diffusion-based framework designed for modeling protein conformational ensembles. DiffEnsemble learns latent dynamical representations from static protein structures in the Protein Data Bank, integrated with the structural profile derived from the AlphaFold Protein Structure Database as conditional guidance during the diffusion process. Benchmarking on 72 protein targets from the ATLAS molecular dynamics simulation dataset demonstrates that DiffEnsemble outperforms existing methods, including BioEmu and AlphaFLOW. Compared with AlphaFLOW, DiffEnsemble achieves improvements of 28.9% and 11.3% in Pearson correlation coefficients for ensemble pairwise root mean square deviation and root mean square fluctuation, respectively. Importantly, DiffEnsemble successfully captures the dominant motions for 42% of the targets. These results demonstrate that latent dynamical information embedded in static structural data can effectively support the modeling of protein conformational ensembles.

bioinformatics↗

Multiomic Screening Unravels the Immunometabolic Signatures and Drug Targets of Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a significant cause of visual impairment in the aging population, with the pathophysiology driven by a complex interplay of genetics, environmental influences and immunometabolic factors. These immunometabolic mechanisms, in particular, those distinguishing between the dry and wet forms of AMD, remain incompletely understood. Utilizing an integrated multiomic approach, incorporating Mendelian Randomization (MR) and single-cell RNA sequencing (scRNA-seq), we have effectively delineated distinct immunometabolic pathways implicated in the development of AMD. Our comprehensive analysis indicates that the androgen-IL10RA-CD16+ monocyte axis could protect against wet AMD. We have also identified several immune and metabolic signatures unique to each AMD subtype, with TNF and Notch signaling pathways being central to disease progression. Furthermore, our analysis, leveraging expression Quantitative Trait Loci (eQTLs) from the Genotype-Tissue Expression (GTEx) project coupled with MR, have highlighted genes such as MTOR, PLA2G7, MAPKAPK3, ANGPTL1, and ARNT as prospective therapeutic targets. The therapeutic potential of these candidate genes was validated with observations from existing drug trial databases. Our robust genetic and transcriptomic approach has identified promising directions for novel AMD interventions, emphasizing the significance of an integrated multiomic approach in tackling this important cause of visual impairment.

immunology↗